4-Substituted Thioquinolines and Thiazoloquinolines: Potent, Selective, and Tween-80 invitro Dependent Families of Antitubercular Agents with Moderate invivo Activity

ChemMedChem (p. 2252-2263) - 9/2011

https://doi.org/10.1002/cmdc.201100309 View at source

• EISSN 1860-7187
• ISSN 1860-7179

• UC3M

A murine model of falciparum-malaria by in vivo selection of competent strains in non-myelodepleted mice engrafted with human erythrocytes

PLoS One - 5/2008

https://doi.org/10.1371/journal.pone.0002252 View at source

• ISSN 1932-6203

• UC3M

A new 'golden age" for the antitubercular target InhA

DRUG DISCOVERY TODAY (p. 492-502) - 3/2017

https://doi.org/10.1016/j.drudis.2016.09.009 View at source

• EISSN 1878-5832
• ISSN 1359-6446

• UC3M

A new molecular approach for cidal vs static antimalarial determination by quantifying mRNA levels

MOLECULAR AND BIOCHEMICAL PARASITOLOGY (p. 171-177) - 11/2011

https://doi.org/10.1016/j.molbiopara.2011.11.003 View at source

• ISSN 0166-6851

• UC3M

Antitubercular drugs for an old target: GSK693 as a promising InhA direct inhibitor

EBioMedicine (p. 291-301) - 5/2016

https://doi.org/10.1016/j.ebiom.2016.05.006 View at source

• ISSN 2352-3964

• UC3M

Comparison of 8 weeks standard treatment (rifampicin plus clarithromycin) vs. 4 weeks standard plus amoxicillin/clavulanate treatment [RC8 vs. RCA4] to shorten Buruli ulcer disease therapy (the BLMs4BU trial): study protocol for a randomized controlled multi-centre trial in Benin

Trials (Trials) (p. 1-17) - 7/2022

https://doi.org/10.1186/s13063-022-06473-9 View at source

• ISSN 1745-6215

• UC3M

Delftia tsuruhatensis TC1 symbiont suppresses malaria transmission by anopheline mosquitoes

SCIENCE (p. 533-540) - 8/2023

10.1126/science.adf8141 View at source

• EISSN 1095-9203
• ISSN 0036-8075

• UC3M

Development of an intracellular screen for new compounds able to inhibit Mycobacterium tuberculosis growth in human macrophages

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (p. 640-645) - 10/2015

https://doi.org/10.1128/aac.01920-15 View at source

• EISSN 1098-6596
• ISSN 0066-4804

• UC3M

Discovery of novel oral protein synthesis inhibitors of mycobacterium tuberculosis that target leucyl-tRNA synthetase

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (p. 6271-6280) - 9/2016

https://doi.org/10.1128/aac.01339-16 View at source

• EISSN 1098-6596
• ISSN 0066-4804

• UC3M

Dual Pharmacophore Pyrithione-Containing Cephalosporins Kill Both Replicating and Nonreplicating Mycobacterium tuberculosis

ACS Infectious Diseases (p. 1433-1445) - 6/2019

https://doi.org/10.1021/acsinfecdis.9b00112 View at source

• ISSN 2373-8227

• UC3M

Antimicrobial Susceptibility Testing for Mycobacterium sps in High-Throughput Format. In: Methods in Molecular Biology

Methods in Molecular Biology (p. 637-648) - 7/2021

Editor: SPRINGER SCIENCE BUSINESS MEDIA B.V.

10.1007/978-1-0716-1460-0_28 View at source

• ISBN 9781071614600

• UC3M

Antimicrobial susceptibility testing for Mycobacterium sp. In: Methods in Molecular Biology

Methods in Molecular Biology (p. 257-268) - 2/2015

Editor: SPRINGER NATURE LIMITED

10.1007/978-1-4939-2450-9_15 View at source

• ISBN 978-1-4939-2449-3

• UC3M